Meningeal lymphatic CGRP signaling governs pain via cerebrospinal fluid efflux and neuroinflammation in migraine models
Journal of Clinical Investigation · 01.08.2024 · 134 (15)
DOI: 10.1172/jci175616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 14.05.2024. Verfasst von Nathan P Nelson-Maney und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Calcitonin Gene-Related Peptide, Meninges, Migraine Disorders, Signal Transduction. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Recently developed antimigraine therapeutics targeting calcitonin gene–related peptide (CGRP) signaling are effective, though their sites of activity remain elusive. Notably, the lymphatic vasculature is responsive to CGRP signaling, but whether meningeal lymphatic vessels (MLVs) contribute to migraine pathophysiology is unknown. Mice with lymphatic vasculature deficient in the CGRP receptor ( Calcrl iLEC mice) treated with nitroglycerin-mediated (NTG-mediated) chronic migraine exhibit reduced pain and light avoidance compared with NTG-treated littermate controls. Gene expression profiles of lymphatic endothelial cells (LECs) isolated from the meninges of Rpl22 HA/+ ;Lyve1 Cre RiboTag mice treated with NTG revealed increased MLV-immune interactions compared with cells from untreated mice. Interestingly, the relative abundance of mucosal vascular addressin cell adhesion molecule 1–interacting (MAdCAM1-interacting) CD4 + T cells was increased in the deep cervical lymph nodes of NTG-treated control mice but not in NTG-treated Calcrl iLEC mice. Treatment of cultured hLECs with CGRP peptide in vitro induced vascular endothelial–cadherin (VE-cadherin) rearrangement and reduced functional permeability. Likewise, intra cisterna magna injection of CGRP caused rearrangement of VE-cadherin, decreased MLV uptake of cerebrospinal fluid (CSF), and impaired CSF drainage in control mice but not in Calcrl iLEC mice. Collectively, these findings reveal a previously unrecognized role for lymphatics in chronic migraine, whereby CGRP signaling primes MLV-immune interactions and reduces CSF efflux.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- NICHD NIH HHS
- American Heart Association
- National Institutes of Health
Zitieren
APA
Nelson-Maney, N. P., Bálint, L., Beeson, A. L., Serafin, D. S., Kistner, B. M., Douglas, E. S., Siddiqui, A. H., Tauro, A. M., & Caron, K. M. (2024). Meningeal lymphatic CGRP signaling governs pain via cerebrospinal fluid efflux and neuroinflammation in migraine models. Journal of Clinical Investigation, 134(15). https://doi.org/10.1172/jci175616
Vancouver
Nelson-Maney NP, Bálint L, Beeson AL, Serafin DS, Kistner BM, Douglas ES, et al. Meningeal lymphatic CGRP signaling governs pain via cerebrospinal fluid efflux and neuroinflammation in migraine models. Journal of Clinical Investigation. 2024;134(15). doi:10.1172/jci175616
BibTeX
@article{NelsonManey2024,
author = {Nelson-Maney, Nathan P and Bálint, László and Beeson, Anna Ls and Serafin, D Stephen and Kistner, Bryan M and Douglas, Elizabeth S and Siddiqui, Aisha H and Tauro, Alyssa M and Caron, Kathleen M},
title = {Meningeal lymphatic CGRP signaling governs pain via cerebrospinal fluid efflux and neuroinflammation in migraine models},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {15},
doi = {10.1172/jci175616}
}
EUVIMED